Measured by its ability to bind Iron(III) dihydroxybenzoic acid [Fe(DHBA)3]. The binding of Fe(DHBA)3 results in the quenching of Trp fluorescence in recombinant Human Lipocalin-2/NGAL Protein (rp176712). The BC50 for this effect is 2.2 μM.
Protein Function: Iron-trafficking protein involved in multiple processes such as apoptosis, innate immunity and renal development. Binds iron through association with 2,5-dihydroxybenzoic acid (2,5-DHBA), a siderophore that shares structural similarities with bacterial enterobactin, and delivers or removes iron from the cell, depending on the context. Iron-bound form (holo-24p3) is internalized following binding to the SLC22A17 (24p3R) receptor, leading to release of iron and subsequent increase of intracellular iron concentration. In contrast, association of the iron-free form (apo-24p3) with the SLC22A17 (24p3R) receptor is followed by association with an intracellular siderophore, iron chelation and iron transfer to the extracellular medium, thereby reducing intracellular iron concentration. Involved in apoptosis due to interleukin-3 (IL3) deprivation: iron-loaded form increases intracellular iron concentration without promoting apoptosis, while iron-free form decreases intracellular iron levels, inducing expression of the proapoptotic protein BCL2L11/BIM, resulting in apoptosis. Involved in innate immunity, possibly by sequestrating iron, leading to limit bacterial growth.
规格
产品名称
Recombinant Human Lipocalin-2/NGAL Protein
别名
重组人Lipocalin-2/NGAL蛋白 | 重组人脂质运载蛋白-2/NGAL 蛋白
英文别名
25 kDa alpha 2 microglobulin related subunit of MMP9 | 25 kDa alpha-2-microglobulin-related subunit of MMP-9 | Alpha 2 microglobulin related protein | HGNC:6526 | HNL | Lcn 2 | Lcn2 | Lipocalin-2 | 24p3 | Migration stimulating factor inhibitor | MSFI | Ne
Measured by its ability to bind Iron(III) dihydroxybenzoic acid [Fe(DHBA)3]. The binding of Fe(DHBA)3 results in the quenching of Trp fluorescence in recombinant Human Lipocalin-2/NGAL Protein (rp176712). The BC50 for this effect is 2.2 μM.
25.6 kDa, under reducing conditions; 25.6 kDa, under non-reducing conditions
分子类型
蛋白质
产品线
生物产品
储存与运输
物理形态
冻干(Lyophilized)
储存缓冲液
Lyophilized from PBS, pH 7.4
复溶
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute at 1.0 mg/mL in sterile distilled water. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
储存条件
-20°C储存,避免反复冻融
运输条件
超低温运输
稳定性与储存
在 -20°C 下可保存 1 年。避免冷冻/解冻循环。
图片
Recombinant Human Lipocalin-2/NGAL Protein - Protein Bioactivity Measured by its ability to bind Iron(III) dihydroxybenzoic acid [Fe(DHBA)3] that is prepared using Iron III (Fe3+) (I141291) and DHBA (D154867). The binding of Fe(DHBA)3 results in the quenching of Trp fluorescence in recombinant Human Lipocalin-2/NGAL Protein (rp176712). The BC50 for this effect is 2.2 μM.
Recombinant Human Lipocalin-2/NGAL Protein (rp176712) - SDS-PAGE 1 μg/lane of Recombinant Human Lipocalin-2/NGAL Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing a band at 25.6 kDa.